Table 3.
Primary and secondary endpoints.
| Endpoint | Women, n = 144 | Men, n = 484 | P value |
|---|---|---|---|
| In-hospital MACE | 11 (7.6) | 30 (6.2) | .54 |
| Cardiac death | 0 (0.0) | 1 (0.2) | 1.00 |
| All myocardial infarction | 11 (7.6) | 29 (6.0) | .48 |
| Non–Q-wave | 11 (7.6) | 25 (5.2) | .26 |
| Q-wave | 0 (0.0) | 4 (0.8) | .58 |
| Target vessel revascularization | 0 (0.0) | 2 (0.4) | 1.00 |
| 30-Day MACE | 12/144 (8.3) | 34/482 (7.1) | .61 |
| Cardiac death | 1/144 (0.7) | 2/482 (0.4) | 1.00 |
| All myocardial infarction | 11/144 (7.6) | 32/482 (6.6) | .67 |
| Non–Q-wave | 11/144 (7.6) | 26/482 (5.4) | .32 |
| Q-wave | 1/144 (0.7) | 6/482 (1.2) | .70 |
| Target vessel revascularization | 1/144 (0.7) | 6/482 (1.2) | .70 |
| Procedural success | |||
| Residual stenosis <50% | 132 (91.7) | 453 (93.6) | .42 |
| Residual stenosis ≤30% | 132 (91.7) | 448 (92.6) | .72 |
| Secondary end points at 30 d | |||
| Target lesion failure | 12/144 (8.3) | 33/482 (6.8) | .54 |
| Ischemia-driven target lesion revascularization | 1/144 (0.7) | 5/482 (1.0) | 1.00 |
| Stent thrombosis (definite or probable) | 0/144 (0.0) | 5/482 (1.0) | .35 |
Values are n (%) or n/N (%).
MACE, major adverse cardiovascular event.